A cohort study of antihyperglycemic medication exposure and survival in patients with gastric cancer
Figure 3.Kaplan-Meier survival curve comparing overall survival between non-diabetic and diabetic patients (p = 0.89) and by antihyperglycemic medication user group (p = 0.052).